
Keralam Health Minister Defends Switch To Indian-Made SMA Drug, Says Supply Will Continue
The story in brief
Parents at SAT Hospital found some Natsmart bottles labeled for clinical trials, raising safety concerns. The government defends the drug's safety and affordability, citing lower costs to sustain free treatment for SMA patients. Opposition leaders demand accountability over procurement and labeling.